As of March 2024 Collegium Pharmaceutical has a market cap of $1.30 Billion. This makes Collegium Pharmaceutical the world's 4791th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $1.30 B | 30.26% |
2023 | $1.00 B | 28.87% |
2022 | $0.77 B | 20.62% |
2021 | $0.64 B | -6.78% |
2020 | $0.69 B | -0.06% |
2019 | $0.69 B | 21.35% |
2018 | $0.57 B | -4.98% |
2017 | $0.60 B | 34.94% |
2016 | $0.44 B | -21.89% |
2015 | $0.57 B |
On Mar 27th, 2024 the market cap of Collegium Pharmaceutical was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
United Therapeutics UTHR | $11.44 B | 775.57% | ๐บ๐ธ USA |
Agile Therapeutics
AGRX | $1.09 M | -99.92% | ๐บ๐ธ USA |
Horizon Therapeutics
HZNP | $26.63 B | 1,936.91% | ๐ฎ๐ช Ireland |
KemPharm KMPH | $0.20 B | -84.67% | ๐บ๐ธ USA |